The 26thTranscatheter Cardiovascular Therapeutics(TCT) is held on September 13th to 17th in Washington D.C, U.S.A. For over 25 years, TCT has been the center of cutting-edge technology communication, experience sharing and education among the world’s intervention physicians. And TCT is currently the world’s most influential meeting specialized in interventional cardiovascular medicine.
R&G is the only one CRO from China attending this event. During the meeting, R&G BD delegations introduced the new released device regulations from CFDA, the strategy and pathway to enter China market, and R&G’s capability and experience of medical device registration and clinical trial operation to all the world’s top and small-middle scale interventional cardiovascular companies and thousands of intervention cardiologists from the world. There is great potential for cooperation in the near future.